Brand Evolution and Engagement

The past few months have been pedal to the metal when it comes to Pharma Commerce’s presence at conferences. As I detail in this month’s “Conference Connect,” LogiPharma USA continues to be a successful show for the industry, thanks to the skillful work of the Worldwide Business Research team in searching out and assembling the topics and SMEs that will resonate most with attendees.

After covering LogiPharma USA in early October, I was fortunate enough last month to report from the Access Insights Conference in Orlando, Fla., an event dedicated to data-driven trends and strategies in drug access commercialization, co-hosted by IntegriChain and Blue Fin Group. As the preferred media partner, Pharma Commerce had exclusive access.

Via Pharma Commerce article and video coverage, topics on the docket included but were not limited to:

• The pharmacy of the future
• Price transparency data in pharma
• A look at the 340B landscape
• Regulatory and legislative hot topics

As part of our video coverage, I also had the chance to pick the brains of Bill Roth, Blue Fin Group’s SVP and managing partner, and a regular contributing expert to Pharma Commerce, as well as Andrew Bronwnlee, a director with Berkeley Research Group.

In separate news, as you've no doubt noticed, I would like to announce that the redesign of the Pharma Commerce print publication is now officially live! We hope that you are as excited about it as we are. This process has been in the making for quite some time—the goal has been to provide a more modern feel to the publication, while keeping its core intact. You’ll notice that each feature and section of the magazine has its own unique layout, and images have taken on an entirely new level of importance to us. This new flare will also be translated over to our website, which is expected to roll out its own redesign in the coming months.

As we close out the year, I greatly appreciate the unwavering support from you, our readers, and can't wait to hear your thoughts and feedback on all of our changes—and ways we can perhaps make your experience with us even better.

Here’s to a prosperous 2024!

Nicholas Saraceno is Pharmaceutical Commerce's Editor. He can be reached at [email protected].